Is JAMA Cardiology a Good Journal? The JAMA Network's Cardiovascular Title
JAMA Cardiology (IF 14.1) is the JAMA Network's cardiovascular journal. Here's when it's the right target, how the JAMA transfer pipeline works, and how it compares to JACC, Circulation, and EHJ.
Associate Professor, Clinical Medicine & Public Health
Author context
Specializes in clinical and epidemiological research publishing, with direct experience preparing manuscripts for NEJM, JAMA, BMJ, and The Lancet.
Journal fit
See whether this paper looks realistic for JAMA Cardiology.
Run the Free Readiness Scan with JAMA Cardiology as your target journal and see whether this paper looks like a realistic submission.
JAMA Cardiology at a glance
Key metrics to place the journal before deciding whether it fits your manuscript and career goals.
What makes this journal worth targeting
- IF 15.6 puts JAMA Cardiology in a visible tier — citations from papers here carry real weight.
- Scope specificity matters more than impact factor for most manuscript decisions.
- Acceptance rate of ~~8% means fit determines most outcomes.
When to look elsewhere
- When your paper sits at the edge of the journal's stated scope — borderline fit rarely improves after submission.
- If timeline matters: JAMA Cardiology takes ~14-21 days. A faster-turnaround journal may suit a grant or job deadline better.
- If open access is required by your funder, verify the journal's OA agreements before submitting.
How to read JAMA Cardiology as a target
This page should help you decide whether JAMA Cardiology belongs on the shortlist, not just whether it sounds impressive.
Question | Quick read |
|---|---|
Best for | JAMA Cardiology focuses on original clinical research that directly informs cardiovascular practice. |
Editors prioritize | Practice-changing clinical trials |
Think twice if | Submitting surrogate endpoint studies as if they're definitive |
Typical article types | Original Investigation, Research Letter, Review |
Quick answer: Yes. JAMA Cardiology (IF 14.1, JCR 2024) is a top-tier cardiovascular journal with the editorial rigor and broad medical reach of the JAMA Network. It's the right venue when your paper has clinical cardiovascular relevance that extends beyond one cardiology subspecialty and can survive JAMA's famously strict editorial process.
The JAMA Network Advantage
JAMA Cardiology isn't just another cardiology journal. It's part of the JAMA Network, which means three things that matter for your paper:
1. JAMA editorial standards. Mandatory statistical review, structured abstracts, strict word limits, and the Key Points format. Papers that can't be compressed into clean JAMA-style presentation struggle here, regardless of the science.
2. Broad medical readership. JAMA Network journals reach general internists, hospitalists, and primary care physicians alongside specialists. A JAMA Cardiology paper gets seen by physicians who don't read JACC or Circulation.
3. The transfer pipeline. When you submit a cardiovascular paper to main JAMA (IF 63.1) and it's rejected, editors may transfer your manuscript to JAMA Cardiology. This transfer pathway is real and accounts for a meaningful fraction of JAMA Cardiology's publications. It's not a consolation prize, it's how the JAMA Network routes strong clinical work to its most appropriate audience.
Key Metrics
Metric | Value |
|---|---|
Impact Factor (JCR 2024) | 14.1 |
5-Year IF | ~16.0 |
Publisher | JAMA Network (AMA) |
Quartile | Q1 in Cardiac and Cardiovascular Systems |
Acceptance rate | ~8-10% |
Median first decision (without review) | ~8 days |
Median first decision (with review) | ~51 days |
APC | Free (subscription model) |
Scope | Clinical cardiology with broad practice relevance |
Where JAMA Cardiology Sits Among the Big Four
Journal | IF (2024) | Affiliation | Acceptance | Best For |
|---|---|---|---|---|
European Heart Journal | 35.6 | ESC | ~10% | ESC guidelines, European/international cardiology |
Circulation | 38.6 | AHA | ~10% | Translational + clinical cardiology |
JACC | 21.0 | ACC | ~10-12% | Broad practice-facing ACC cardiology |
JAMA Cardiology | 14.1 | JAMA Network | ~8-10% | Clinical cardiology with JAMA editorial discipline |
JAMA Cardiology vs JACC: Both want clinical cardiology with broad relevance. The difference is editorial style. JACC gives more room for detailed clinical discussion. JAMA Cardiology demands compression, if your paper can't be distilled into Key Points and a structured abstract without losing its impact, JACC may be the better fit. If the paper is stronger when compressed, JAMA Cardiology's editorial discipline actually helps.
JAMA Cardiology vs Circulation: Circulation accepts more translational and mechanistic cardiovascular work. If your paper has a basic science component, Circulation is more welcoming. JAMA Cardiology wants clinical papers where the practice relevance is immediate and clear.
The IF gap: JAMA Cardiology's IF (14.1) is noticeably below JACC (21.0), Circulation (38.6), and EHJ (39.3). This doesn't make it a lesser journal, the JAMA Network brand carries significant weight in promotion committees. But if IF comparisons drive decisions in your department, be aware of the numbers.
Submit if
- Your paper has broad cardiovascular clinical relevance that survives JAMA-style compression
- The practice implications are clear and immediate, not speculative or future-oriented
- You can write clean Key Points that capture the paper's value in three bullet points
- The paper would benefit from reaching a general medical audience beyond cardiologists
Journal fit
See whether this paper looks realistic for JAMA Cardiology.
Run the scan with JAMA Cardiology as the target. Get a manuscript-specific fit signal before you commit.
Think twice if
- The paper has a strong translational or mechanistic component (try Circulation instead)
- The detailed clinical argument is essential and would be lost under JAMA word limits
- The paper is subspecialty cardiology without cross-cardiology relevance
- IF comparisons in your department would penalize 14.8 vs 21.0+ at the other flagships
The Editorial Discipline Factor
JAMA Cardiology's editorial process is genuinely different from JACC, Circulation, or EHJ. The statistical review is mandatory and rigorous. The structured abstract format forces clarity. The word limits are strict. The Key Points box requires you to state what's known, what the study adds, and what it means for practice, in plain language.
Some authors find this liberating. Others find it constraining. If your paper's strength is in the data and the conclusion (not in the narrative) JAMA Cardiology's format works in your favor. If the paper requires nuanced clinical argumentation that needs space, JACC or Circulation may serve it better.
The 8-day median to first decision without review means triage is fast. If JAMA Cardiology desk-rejects, you haven't lost much time. That speed makes it a reasonable first-choice target even when you're not certain of the fit.
Before submitting, a JAMA Cardiology scope and readiness check can assess whether your paper's clinical argument is strong enough for JAMA Cardiology's editorial standards.
Before you submit
A JAMA Cardiology submission readiness check identifies the specific framing and scope issues that trigger desk rejection before you submit.
JAMA Cardiology within the JAMA Network
JAMA Cardiology (IF ~14) is part of the JAMA Network, 12 specialty journals plus JAMA Network Open. Papers desk-rejected from JAMA can be redirected to JAMA Cardiology. The journal uses JAMA's rigorous statistical review process.
JAMA Cardiology does not publish basic cardiovascular science. It wants clinical cardiology with clear implications for physician decision-making. The editorial identity is pragmatic: what should cardiologists do differently based on this evidence?
Compared to JACC (IF ~21) and Circulation (IF ~35), JAMA Cardiology is more accessible but carries strong JAMA Network prestige. It is the natural target for cardiovascular papers that are too specialized for JAMA but too strong for general cardiology journals.
A JAMA Cardiology desk-rejection risk check scores fit against the journal's editorial bar.
Frequently asked questions
JAMA Cardiology has a 2024 JCR impact factor of 14.1. It is ranked Q1 in Cardiac and Cardiovascular Systems. While its IF is lower than JACC (21.0), Circulation (38.6), and European Heart Journal (39.3), it carries the JAMA Network brand and editorial standards, which are highly valued in clinical medicine.
When you submit a cardiovascular paper to main JAMA (IF 63.1) and it's rejected, editors may offer to transfer your manuscript to JAMA Cardiology. This transfer is real and common. The paper enters JAMA Cardiology's review process with a fresh evaluation, but the JAMA-quality formatting and methodology review carries forward. This is a legitimate pathway, not a consolation prize.
JAMA Cardiology applies JAMA Network editorial discipline: mandatory statistical review, structured abstracts, strict word limits, and the Key Points format. JACC gives authors more space for detailed clinical arguments. JAMA Cardiology also reaches a broader medical audience through the JAMA Network, while JACC's readership is primarily cardiologists through ACC.
Yes. JAMA Cardiology is universally recognized as a top-tier cardiology journal. It's part of the JAMA Network, which carries weight across all of academic medicine. For promotion and tenure committees, a JAMA Cardiology publication signals that the work passed one of the most rigorous editorial screens in medicine.
Sources
- JAMA Cardiology Author Instructions, JAMA Network.
- JAMA Cardiology About Page, JAMA Network.
- Clarivate Journal Citation Reports (JCR 2024, released June 2025).
Final step
See whether this paper fits JAMA Cardiology.
Run the Free Readiness Scan with JAMA Cardiology as your target journal and get a manuscript-specific fit signal before you commit.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
- JAMA Cardiology Submission Guide
- How to Avoid Desk Rejection at JAMA Cardiology
- JAMA Cardiology Review Time: What Authors Can Actually Expect
- JAMA Cardiology Impact Factor 2026: 14.1, Q1, Rank 7/230
- JAMA Cardiology Cover Letter: What Editors Actually Need to See
- JAMA Cardiology Formatting Requirements: The Submission Package Guide
Compare alternatives
Supporting reads
Conversion step
See whether this paper fits JAMA Cardiology.
Anthropic Privacy Partner. Zero-retention manuscript processing.